Therapeutic Potential of Regorafenib—A Multikinase Inhibitor in Pulmonary Hypertension

Pulmonary hypertension (PH) is characterized by a progressive elevation of mean arterial pressure followed by right ventricular failure and death. Previous studies have indicated that numerous inhibitors of receptor tyrosine kinase signaling could be either beneficial or detrimental for the treatmen...

Descripción completa

Detalles Bibliográficos
Autores principales: Veeroju, Swathi, Kojonazarov, Baktybek, Weiss, Astrid, Ghofrani, Hossein Ardeschir, Weissmann, Norbert, Grimminger, Friedrich, Seeger, Werner, Novoyatleva, Tatyana, Schermuly, Ralph Theo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867319/
https://www.ncbi.nlm.nih.gov/pubmed/33540939
http://dx.doi.org/10.3390/ijms22031502

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7867319/
https://www.ncbi.nlm.nih.gov/pubmed/33540939
http://dx.doi.org/10.3390/ijms22031502

Ejemplares similares